Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00006259 · ClinicalTrials.gov registry record · Phase 2

Stereotactic Radiation Therapy in Treating Patients With Brain Metastases

A Phase 2 study, sponsored by Case Comprehensive Cancer Center.

Completed
Registry status
Phase 2
Development phase
10
Enrollment target

NCT00006259: Completed Phase 2 study, sponsored by Case Comprehensive Cancer Center.

NCT00006259 is a Phase 2 study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 10 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00006259, a Phase 2 study, has completed, sponsored by Case Comprehensive Cancer Center.

COMPLETED
Registry status
Phase 2
Development phase
10 participants
Enrollment target

Study Summary

RATIONALE: Stereotactic radiation therapy may be able to deliver x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: Phase II trial to study the effectiveness of stereotactic radiation therapy in treating patients who have brain metastases.

Interventions

  • RADIATION stereotactic radiosurgery

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2000-01
Est. Completion 2005-02
Phase Phase 2
Case Comprehensive Cancer Center

407 total trials

What the finished NCT00006259 record still lists

NCT00006259 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 1 intervention - of which stereotactic radiosurgery is the first listed.

NCT00006259 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00006259 about?

NCT00006259 is a clinical study titled "Stereotactic Radiation Therapy in Treating Patients With Brain Metastases". RATIONALE: Stereotactic radiation therapy may be able to deliver x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: Phase II trial to study the effectiveness of stereotactic radiation therapy in treating patients who have brain metastases.

What is the current status of trial NCT00006259?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2000-01. Estimated completion is 2005-02.

What interventions are being tested in trial NCT00006259?

The interventions under investigation include: stereotactic radiosurgery (RADIATION).

Who is sponsoring clinical trial NCT00006259?

This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00006259's enrollment target sits among peer trials

10 1968th of 2000 higher than 12 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00006259, the US trial registry maintained by the National Library of Medicine. NCT00006259 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.